Variants with greater impact.
Some changes in specific genes may be related to an increased chance of certain conditions and motivate targeted evaluation.
Longevo and Longevo Premium
Longevo adds genetic information to preventive care and uses a sample collected with a mouth swab. Longevo Premium maintains the same test and adds pre-test consultation, post-test consultation and annual clinical reassessment of data for four consecutive years.
Genetics complements habits, routine tests, history and clinical monitoring.
Individualized prevention
What genetics can add to prevention.
Genetic information can highlight predispositions and risk estimates that deserve attention. It is interpreted together with personal and family history, age, habits, clinical measurements and tests.
Many genetic differences added up.
Some calculations combine many differences in DNA to estimate risk compared to a reference population. The result has limits and does not predict a person's future.
History, environment and care.
DNA alone does not explain the future of health. Exposures, habits, age, other conditions and access to care also play a part.
Two ways to access
Longevo is the test. Longevo Premium adds tracking.
The genetic content and oral swab sample collection are the same on both journeys. In Premium, clinical support and the follow-up period change.
- 01
Longevo
It is the preventive genetic test. The report organizes the findings among the information analyzed and must be taken to a professional who knows your health.
- 02
Longevo Premium
It offers the same genetic content as Longevo, pre-test consultation, post-test consultation and annual clinical re-evaluation of data for four consecutive years.
- 03
In both cases
The result is not a diagnosis of all conditions, does not guarantee prevention and does not authorize changes in screening, habits or medications without appropriate evaluation.
What the test doesn't promise
Knowing risk is not predicting the future.
The usefulness depends on what the test analyzes, the quality of the data, the available evidence and the way in which the result is integrated into care.
- 01
Risk result does not confirm disease
A predisposition indicates possibility, not certainty. Some people will never develop the condition; others may become ill without an identified variant.
- 02
Negative result does not eliminate risk
The test evaluates a defined set of information. History, age, habits and non-genetic factors may still justify screening.
- 03
Scores have population context
Performance may vary depending on the reference population, and the number should not be interpreted outside of the model and clinical data used.
- 04
Prevention continues over time
Consultations, vaccines, habits and tests recommended for age and history are still necessary because of the genetic result.
After the report
Each type of result asks a different question.
The interpretation distinguishes findings with evidence, risk estimates, lack of conclusive finding and information that is still uncertain.
Relevant finding
Ask what it means to you, whether it needs confirmation, which specialist should participate and whether family members can benefit from evaluation.
risk score
Understand the reference population, the clinical factors considered and whether the result actually changes a preventive recommendation.
No conclusive finding
Confirm what care is still indicated by age, family history, symptoms and other health information.
Uncertain variant
A VUS does not confirm risk and should not guide surgery, surveillance, prognosis, treatment, or predictive testing. In all NeoGenomica tests, the reported VUS are included in the Infinity VUS follow-up.
Frequently asked questions
Questions about choosing between Longevo and Longevo Premium.
Does this test tell me what diseases I will have?
No. It can identify predispositions or risk estimates among the information analyzed. This does not determine if, when, or how strongly a condition will occur.
Can I stop taking my routine tests if the result is low?
No. Screenings and consultations continue to be defined by the team according to age, history, clinical factors and applicable recommendations.
What is the practical difference between Longevo and Longevo Premium?
The genetic content is the same. Longevo Premium includes a consultation before the test, one after the report and a clinical re-evaluation of the data each year, for four consecutive years. The reassessment revisits the data already generated; it is not a new sequencing nor an additional annual medical appointment.
How is Longevo collected?
Longevo and Longevo Premium use a buccal swab. Follow the kit instructions to collect cells from the inside of the cheek, identify the material, and send it to the laboratory.
Does a finding mean that my family members also have the variant?
Not necessarily. The possibility depends on the gene and the inheritance pattern. Each family member decides separately whether they want an evaluation and authorizes their own test.
Discover the options
Compare the test and the accompanied journey.
The technical pages show what each solution currently analyzes and access details.
Next step
Choose the journey that matches the support you are looking for.
Get to know Longevo, compare the Premium journey and talk to the team about access, sample collection and next steps.
For patients and families
Information for each stage of the journey.
Start with the topic that comes closest to your question.
